235 related articles for article (PubMed ID: 31690264)
21. RNF168 E3 ligase participates in ubiquitin signaling and recruitment of SLX4 during DNA crosslink repair.
Katsuki Y; Abe M; Park SY; Wu W; Yabe H; Yabe M; van Attikum H; Nakada S; Ohta T; Seidman MM; Kim Y; Takata M
Cell Rep; 2021 Oct; 37(4):109879. PubMed ID: 34706224
[TBL] [Abstract][Full Text] [Related]
22. Human DNA helicase HELQ participates in DNA interstrand crosslink tolerance with ATR and RAD51 paralogs.
Takata K; Reh S; Tomida J; Person MD; Wood RD
Nat Commun; 2013; 4():2338. PubMed ID: 24005565
[TBL] [Abstract][Full Text] [Related]
23. Ubiquitylation and the Fanconi anemia pathway.
Garner E; Smogorzewska A
FEBS Lett; 2011 Sep; 585(18):2853-60. PubMed ID: 21605559
[TBL] [Abstract][Full Text] [Related]
24. E3 ubiquitin ligase HOIP attenuates apoptotic cell death induced by cisplatin.
MacKay C; Carroll E; Ibrahim AFM; Garg A; Inman GJ; Hay RT; Alpi AF
Cancer Res; 2014 Apr; 74(8):2246-2257. PubMed ID: 24686174
[TBL] [Abstract][Full Text] [Related]
25. A phosphorylation-and-ubiquitylation circuitry driving ATR activation and homologous recombination.
Dubois JC; Yates M; Gaudreau-Lapierre A; Clément G; Cappadocia L; Gaudreau L; Zou L; Maréchal A
Nucleic Acids Res; 2017 Sep; 45(15):8859-8872. PubMed ID: 28666352
[TBL] [Abstract][Full Text] [Related]
26. DNA2 and EXO1 in replication-coupled, homology-directed repair and in the interplay between HDR and the FA/BRCA network.
Karanja KK; Cox SW; Duxin JP; Stewart SA; Campbell JL
Cell Cycle; 2012 Nov; 11(21):3983-96. PubMed ID: 22987153
[TBL] [Abstract][Full Text] [Related]
27. Convergence of the fanconi anemia and ataxia telangiectasia signaling pathways.
Taniguchi T; Garcia-Higuera I; Xu B; Andreassen PR; Gregory RC; Kim ST; Lane WS; Kastan MB; D'Andrea AD
Cell; 2002 May; 109(4):459-72. PubMed ID: 12086603
[TBL] [Abstract][Full Text] [Related]
28. The Fanconi anemia ID2 complex: dueling saxes at the crossroads.
Boisvert RA; Howlett NG
Cell Cycle; 2014; 13(19):2999-3015. PubMed ID: 25486561
[TBL] [Abstract][Full Text] [Related]
29. Identification of UHRF2 as a novel DNA interstrand crosslink sensor protein.
Motnenko A; Liang CC; Yang D; Lopez-Martinez D; Yoshikawa Y; Zhan B; Ward KE; Tian J; Haas W; Spingardi P; Kessler BM; Kriaucionis S; Gygi SP; Cohn MA
PLoS Genet; 2018 Oct; 14(10):e1007643. PubMed ID: 30335751
[TBL] [Abstract][Full Text] [Related]
30. Cul4 E3 ubiquitin ligase regulates ovarian cancer drug resistance by targeting the antiapoptotic protein BIRC3.
Hu X; Meng Y; Xu L; Qiu L; Wei M; Su D; Qi X; Wang Z; Yang S; Liu C; Han J
Cell Death Dis; 2019 Feb; 10(2):104. PubMed ID: 30718461
[TBL] [Abstract][Full Text] [Related]
31. The BRIP1 helicase functions independently of BRCA1 in the Fanconi anemia pathway for DNA crosslink repair.
Bridge WL; Vandenberg CJ; Franklin RJ; Hiom K
Nat Genet; 2005 Sep; 37(9):953-7. PubMed ID: 16116421
[TBL] [Abstract][Full Text] [Related]
32. Chk1-mediated phosphorylation of FANCE is required for the Fanconi anemia/BRCA pathway.
Wang X; Kennedy RD; Ray K; Stuckert P; Ellenberger T; D'Andrea AD
Mol Cell Biol; 2007 Apr; 27(8):3098-108. PubMed ID: 17296736
[TBL] [Abstract][Full Text] [Related]
33. Dedicated to the core: understanding the Fanconi anemia complex.
Gurtan AM; D'Andrea AD
DNA Repair (Amst); 2006 Sep; 5(9-10):1119-25. PubMed ID: 16784902
[TBL] [Abstract][Full Text] [Related]
34. Dysregulation of CUL4A and CUL4B Ubiquitin Ligases in Lung Cancer.
Jia L; Yan F; Cao W; Chen Z; Zheng H; Li H; Pan Y; Narula N; Ren X; Li H; Zhou P
J Biol Chem; 2017 Feb; 292(7):2966-2978. PubMed ID: 27974468
[TBL] [Abstract][Full Text] [Related]
35. Crosstalk between BRCA-Fanconi anemia and mismatch repair pathways prevents MSH2-dependent aberrant DNA damage responses.
Peng M; Xie J; Ucher A; Stavnezer J; Cantor SB
EMBO J; 2014 Aug; 33(15):1698-712. PubMed ID: 24966277
[TBL] [Abstract][Full Text] [Related]
36. CUL4 E3 ligase regulates the proliferation and apoptosis of lung squamous cell carcinoma and small cell lung carcinoma.
Li T; Wu S; Jia L; Cao W; Yao Y; Zhao G; Li H
Cancer Biol Med; 2020 May; 17(2):357-370. PubMed ID: 32587774
[No Abstract] [Full Text] [Related]
37. Caffeine Has a Synergistic Anticancer Effect with Cisplatin via Inhibiting Fanconi Anemia Group D2 Protein Monoubiquitination in Hepatocellular Carcinoma Cells.
Oda Y; Hidaka M; Suzuki A
Biol Pharm Bull; 2017 Nov; 40(11):2005-2009. PubMed ID: 28855448
[TBL] [Abstract][Full Text] [Related]
38. Replication Protein A Availability during DNA Replication Stress Is a Major Determinant of Cisplatin Resistance in Ovarian Cancer Cells.
Bélanger F; Fortier E; Dubé M; Lemay JF; Buisson R; Masson JY; Elsherbiny A; Costantino S; Carmona E; Mes-Masson AM; Wurtele H; Drobetsky E
Cancer Res; 2018 Oct; 78(19):5561-5573. PubMed ID: 30072396
[TBL] [Abstract][Full Text] [Related]
39. The FANCM/FAAP24 complex is required for the DNA interstrand crosslink-induced checkpoint response.
Huang M; Kim JM; Shiotani B; Yang K; Zou L; D'Andrea AD
Mol Cell; 2010 Jul; 39(2):259-68. PubMed ID: 20670894
[TBL] [Abstract][Full Text] [Related]
40. Human SNM1B is required for normal cellular response to both DNA interstrand crosslink-inducing agents and ionizing radiation.
Demuth I; Digweed M; Concannon P
Oncogene; 2004 Nov; 23(53):8611-8. PubMed ID: 15467758
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
